Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-22 09:58 am Purchase |
2025-07-15 | 13G | Praxis Precision Medicines, Inc. PRAX |
Perceptive Advisors LLC | 1,362,503 6.690% |
381,609 (+38.90%) |
Filing History |
| 2025-06-24 4:42 pm Purchase |
2025-06-20 | 13D | Nautilus Biotechnology, Inc. NAUT |
Perceptive Advisors LLC | 12,815,113 10.100% |
220,902 (+1.75%) |
Filing History |
| 2025-06-04 4:05 pm Sale |
2025-06-02 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Perceptive Advisors LLC | 0 0.000% |
-3,104,139 (Position Closed) |
Filing History |
| 2025-05-15 6:20 pm Sale |
2025-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
Perceptive Advisors LLC | 4,423,441 6.800% |
-1,011,769 (-18.62%) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Perceptive Advisors LLC | 7,874,348 8.800% |
1,100,000 (+16.24%) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Perceptive Advisors LLC | 444,649 6.300% |
14,649 (+3.41%) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Beta Bionics, Inc. BBNX |
Perceptive Advisors LLC | 2,203,840 5.100% |
2,203,840 (New Position) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Perceptive Advisors LLC | 21,464,527 7.000% |
-2,781,425 (-11.47%) |
Filing History |
| 2025-05-15 4:30 pm Unchanged |
2025-03-31 | 13G | Contineum Therapeutics, Inc. Class A Common Stock CTNM |
Perceptive Advisors LLC | 1,441,249 7.500% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Perceptive Advisors LLC | 1,481,481 1.600% |
-3,249,669 (-68.69%) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Arcellx, Inc. ACLX |
Perceptive Advisors LLC | 2,926,478 5.300% |
-962,191 (-24.74%) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Perceptive Advisors LLC | 980,894 4.800% |
-848,841 (-46.39%) |
Filing History |
| 2025-05-15 4:30 pm Unchanged |
2025-03-31 | 13G | Surrozen, Inc. SRZN |
Perceptive Advisors LLC | 166,666 1.900% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Outset Medical, Inc. OM |
Perceptive Advisors LLC | 1,208,334 6.700% |
1,208,334 (New Position) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-03-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Perceptive Advisors LLC | 6,395,546 6.100% |
1,231,059 (+23.84%) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Evolus, Inc. EOLS |
Perceptive Advisors LLC | 4,129,142 6.400% |
-1,227,480 (-22.92%) |
Filing History |
| 2025-05-15 4:30 pm Purchase |
2025-05-12 | 13G | Biodesix, Inc. BDSX |
Perceptive Advisors LLC | 7,673,880 5.100% |
1,000,000 (+14.98%) |
Filing History |
| 2025-05-15 4:30 pm Unchanged |
2025-03-31 | 13G | Ensysce Biosciences, Inc. ENSC |
Perceptive Advisors LLC | 86,666 3.700% |
0 (Unchanged) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Instil Bio, Inc. TIL |
Perceptive Advisors LLC | 0 0.000% |
-345,545 (Position Closed) |
Filing History |
| 2025-05-15 4:30 pm Sale |
2025-03-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Perceptive Advisors LLC | 12,808,788 3.800% |
-9,303,478 (-42.07%) |
Filing History |